Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.
about
Do stroke models model stroke?Perioperative sleep apnea: a real problem or did we invent a new disease?Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the TargetHistone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic InjuryFrom rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemiaPreconditioning for traumatic brain injuryAdenosine kinase: exploitation for therapeutic gain.Hypoxia: developments in basic science, physiology and clinical studiesRole of MicroRNAs in innate neuroprotection mechanisms due to preconditioning of the brainGlucocorticoids and preterm hypoxic-ischemic brain injury: the good and the badBiomarkers for ischemic preconditioning: finding the respondersGenetic animal models of preconditioningHyperbaric oxygen preconditioning: a reliable option for neuroprotectionRole of Homocysteine in the Ischemic Stroke and Development of Ischemic ToleranceHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairThe divergent roles of autophagy in ischemia and preconditioningIschemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-strokeTsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagySleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working GroupTIGAR contributes to ischemic tolerance induced by cerebral preconditioning through scavenging of reactive oxygen species and inhibition of apoptosisInfluence of stochastic gene expression on the cell survival rheostat after traumatic brain injuryKATP channel subunits in rat dorsal root ganglia: alterations by painful axotomyThe immunology of stroke: from mechanisms to translationIschemic preconditioning and clinical scenarios.High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.Episodes of Fall Asleep During Day Time in an Elder Woman with Vascular Dementia: Impact on Cerebral Ischeamic Tolerance and Utility of ECG Holter Monitoring.Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotectionFetal asphyctic preconditioning alters the transcriptional response to perinatal asphyxiaBi-directionally protective communication between neurons and astrocytes under ischemia.Activation of K(2)P channel-TREK1 mediates the neuroprotection induced by sevoflurane preconditioningIs there a place for cerebral preconditioning in the clinic?Neuroprotection of microRNA in neurological disorders (Review)Preconditioning stimuli induce autophagy via sphingosine kinase 2 in mouse cortical neurons.Toll-like receptors and ischemic brain injury.Mitochondria: the missing link between preconditioning and neuroprotection.MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex.ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning.3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow
P2860
Q24288828-AF409F27-72B5-4E86-AE1C-BF75E929249BQ26752444-D8A1F142-8541-452B-B5F4-0EE2CE7897A2Q26752592-124083B9-C5C6-434E-A389-B8CB09CD74D5Q26801660-5C097F9E-2AD2-4C09-BED3-09A74AA562E8Q26825167-B8CFEB48-5829-4C49-BEB6-00B092405879Q26830665-F36FCC45-CD97-4FEE-B7DC-994D83A1E450Q26852056-A53974E2-D500-4CEC-A3C4-3A54CE7E5C43Q26865820-4DC6DE8E-10EE-4946-8F0F-931A8050C0D4Q27003832-04E0413C-F8F5-47B0-A1CB-9F1ED483473BQ27014745-58332AC8-E23E-457C-BB99-7A45F5134D10Q27015878-4B95A8AD-C61A-428E-811B-5658E2E176CEQ27022029-A1000FAA-3F04-4DEE-8F86-1EEFD9367F66Q28069280-3567C21C-1FCA-4EA7-B643-70FFC7450C17Q28073469-753C0E3A-0F26-4E5C-88F6-5529552C2B3AQ28078211-E6BC6574-5750-4B01-8002-48DC5E30B79DQ28082209-8B7B4561-A0F9-422D-BFD2-2601EC78F72AQ28082979-04BE99FE-51BB-4A1A-AFE6-E7149385C477Q28286093-8F97D4CA-C15A-4986-8B1E-389C809F963EQ28391571-0B022FDD-393A-4881-894D-2BF93DABC722Q28395878-ED8D3A2F-B673-46FE-BAA3-DBA1BB1AB7C8Q28476525-12335392-FE11-466A-97B4-18CCB0540053Q28577176-5ECB550F-6B97-48B0-B791-C12D41EA3BFDQ29620066-7BB4C9D5-659C-4D41-BA3B-30B3ED438738Q30450344-940F8A75-A33A-4868-A7A1-FE578D7A7AFFQ30572344-CF39DA66-770A-46F5-AC37-59C1DC76395BQ30884854-4580CC76-7C45-4CF4-959E-9F72026C70F6Q33159532-0CE19256-00D4-44B2-AD37-735017252299Q33694824-0301CBDF-6551-4E16-9EF9-4C2522ADC2DAQ33729828-8B8D47B5-90D3-47A4-A79D-D811246E73DDQ33735865-45732D62-8A7B-4102-B4F3-D76AC646CCD7Q33773040-57D5AE8F-CC23-42DE-BCE3-E181B95CF5D7Q33919637-3604C9E3-A7CA-484F-A452-8DE230EA3B0CQ33932509-1F515CD1-91B2-4C0E-9B3C-CE1B7BC97410Q33947149-AE281FE3-8118-4F1B-827A-26B11DDBE3A2Q33972758-1DC19865-CA6D-479E-A33E-F1CD306F750FQ34073859-B7BBC03C-0B95-44FE-B8BA-EEEA3264A69BQ34101214-FCEC1EF0-E117-4CFA-97EE-8966FAB15438Q34112461-9FDFE3B3-E86E-4A12-9B84-82B4D56EC956Q34116124-9C983A89-E70C-4C55-950B-8E120B39B95EQ34153446-B4828894-4B9A-486C-B16B-9C4F4A36F2C3
P2860
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preconditioning and tolerance ...... al strategies to clinical use.
@en
Preconditioning and tolerance ...... al strategies to clinical use.
@nl
type
label
Preconditioning and tolerance ...... al strategies to clinical use.
@en
Preconditioning and tolerance ...... al strategies to clinical use.
@nl
prefLabel
Preconditioning and tolerance ...... al strategies to clinical use.
@en
Preconditioning and tolerance ...... al strategies to clinical use.
@nl
P2860
P1433
P1476
Preconditioning and tolerance ...... al strategies to clinical use.
@en
P2093
Kyra Becker
P2860
P304
P356
10.1016/S1474-4422(09)70054-7
P577
2009-04-01T00:00:00Z